SESN2 and cardiac hypertrophy: In our study, the phosphorylation levels of AMPK in young WT, aged WT, and Y-Sesn2 KO mice with cardiac hypertrophy increased after TAC, but there were no significant differences among the three groups; thus, Sesn2 may inhibit mTORC1 independent of the AMPK–TSC2 pathway.